LPWM LLC’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,299
Closed -$710K 65
2022
Q1
$710K Sell
5,299
-150
-3% -$19.5K 0.35% 34
2021
Q4
$832K Sell
5,449
-100
-2% -$15.5K 0.44% 29
2021
Q3
$882K Hold
5,549
0.52% 24
2021
Q2
$905K Sell
5,549
-299
-5% -$46.1K 0.54% 23
2021
Q1
$886K Hold
5,848
0.6% 23
2020
Q4
$886K Sell
5,848
-702
-11% -$100K 0.66% 22
2020
Q3
$895K Sell
6,550
-117
-2% -$15.9K 0.73% 24
2020
Q2
$911K Buy
6,667
+196
+3% +$25K 0.83% 22
2020
Q1
$697K Buy
6,471
+320
+5% +$36.8K 0.76% 20
2019
Q4
$741K Buy
+6,151
New +$686K 0.69% 18

Other funds holding IBB

LPWM LLC's IBB Position: Q2 2022 in Review

LPWM LLC sold out of iShares Biotechnology ETF (IBB) in Q2 2022, closing a stake of 5,299 shares — an estimated $710K sold.

LPWM LLC first reported a position in IBB in Q4 2019 and held it in 10 quarters. The position peaked at $911K in Q2 2020. 858 funds tracked by Wall St. Rank hold IBB as of Q2 2022.

  • LPWM LLC reported no remaining iShares Biotechnology ETF position as of Q2 2022 after selling out during the quarter.
  • LPWM LLC sold 5,299 iShares Biotechnology ETF shares in Q2 2022, an estimated $710K.
  • LPWM LLC first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 10 quarters.
  • LPWM LLC's iShares Biotechnology ETF position peaked at $911K in Q2 2020.
  • 858 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2022.

Based on LPWM LLC's 13F filing for Q2 2022, filed 15 Aug 2022.